Mounjaro tirzepatide injection 5mg: what it is and when it matters

What the trial data tells us about the dose-escalation journey

SURMOUNT-1, the pivotal trial published in the New England Journal of Medicine, randomised 2,539 adults with obesity over 72 weeks. Weight loss accumulated progressively as doses increased, which is exactly why the schedule is designed as it is. The first four weeks at 2.5mg are about giving the gut-hormone system time to adjust; moving to 5mg is where the medicine begins its work in earnest. Participants at the 5mg, 10mg and 15mg arms all lost meaningful weight, with the greatest reductions at 15mg, but the trajectory starts here. The point is not that 5mg is a halfway house, it is a therapeutic dose in its own right, and for some people whose prescriber judges the evidence carefully, it may be the appropriate long-term maintenance strength. If you want to explore the full dose landscape, the tirzepatide injection doses overview sets out what the clinical schedule looks like from start to finish.

NICE's appraisal of tirzepatide, TA1026, recommends that if someone has not lost at least 5% of their body weight after six months at the highest tolerated dose, continuing treatment is reviewed. That framing matters: the goal is to find the dose that works, not to rush upward regardless.

Why 5mg is not just a stepping stone you pass through quickly

There is a common assumption that the starter dose exists to be discarded as fast as possible. That is worth gently setting aside. The 2.5mg period genuinely does something useful: it reduces the likelihood of nausea and GI upset by letting the body adapt before a stronger signal arrives. Moving from 2.5mg to the 5mg Mounjaro pen at week five is not a concession, it is the designed route. Some people tolerate 5mg smoothly for a month and move to 7.5mg; others find that 5mg is working well and their prescriber keeps them there for longer. Neither path is wrong. Dose decisions belong to the clinical review, not to a schedule someone read on a forum.

Side effects at 5mg follow the GI-led pattern common across the tirzepatide range: nausea, loose stools, indigestion and reduced appetite are the most frequently reported. They are typically most noticeable in the first week or two at a new dose and settle for most people. Serious reactions are uncommon; if you experience severe stomach pain that radiates to the back, seek medical help promptly, the MHRA Yellow Card scheme is the right place to report any side effect that concerns you. Full side-effect detail is in the Patient Information Leaflet included with every pen.

Who the 5mg dose is intended for, and the prescriber's role in deciding

The Mounjaro licence covers adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition, for example high blood pressure, raised cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. Importantly, BMI is a starting point: a prescriber also looks at medical history, current medicines, and any contraindications before approving treatment at any strength. You can read more about how Mounjaro fits into UK weight management on the Mounjaro overview.

Under-18s are not licensed for tirzepatide. Pregnancy, breastfeeding and trying to conceive are contraindications; women using oral contraceptives should add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because absorption of the pill may be reduced, the NHS England weight-management injections guidance sets this out clearly alongside advice on HRT and surgery.

What private access looks like, and how pricing fits in

Mounjaro is available privately through GPhC-registered online pharmacies without the NHS waiting list, provided someone meets the clinical criteria. Because Eli Lilly adjusted UK list prices in late 2025, private monthly costs now vary considerably by provider and dose, typically somewhere between £149 and £375 depending on strength and where you go. The Eli Lilly Mounjaro price increase page explains the context behind that shift. What any legitimate price should include is the consultation, prescription, clinical review and dispensing, if a quote only covers the pen itself, it is worth asking what else you are paying for separately.

At 5mg specifically, private supply means a prescriber has reviewed your health record, confirmed suitability, and the pen is dispensed from a regulated pharmacy. The tirzepatide injection dosage guide covers how ongoing clinical reviews work as doses change over time. For anyone considering the step up to higher strengths, the evidence behind the 15mg Mounjaro injection and the full results picture is covered separately. If you are ready to discuss whether Mounjaro is right for you, start your free consultation with our prescribers.